These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 287557)

  • 21. Phase II evaluation of aclarubicin in refractory adult acute leukemia: a Southwest Oncology Group Study.
    Dabich L; Bull FE; Beltran G; Athens JW; Coltman CA; Weick JK; Van Slyck EJ; Amare M
    Cancer Treat Rep; 1986 Aug; 70(8):967-9. PubMed ID: 3460700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I-II trial of mitoxantrone in acute leukemia.
    Arlin ZA; Silver R; Cassileth P; Armentrout S; Gams R; Daghestani A; Coleman M; Schoch I; Dukart G
    Cancer Treat Rep; 1985 Jan; 69(1):61-4. PubMed ID: 3855386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rubidazone in the treatment of recurrent acute leukemia in children. A Pediatric Oncology Group Study.
    Ragab AH; Boyett JM; Frankel L; Falletta J
    Cancer; 1986 Apr; 57(8):1461-3. PubMed ID: 3948126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I clinical investigation of homoharringtonine.
    Legha SS; Keating M; Picket S; Ajani JA; Ewer M; Bodey GP
    Cancer Treat Rep; 1984 Sep; 68(9):1085-91. PubMed ID: 6478448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience.
    Catimel G; Spielmann M; Dieras V; Tubiana-Hulin M; Bonneterre J; Pouillart P; Kayitalire L; Guastalla JP; Graffand N; Garet F; Dumortier A; Pellae-Cosset B
    Semin Oncol; 1997 Feb; 24(1 Suppl 3):S8-12. PubMed ID: 9071333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isophosphamide therapy for hematologic malignancies in patients refractory to prior treatment.
    Rodriguez V; McCredie KB; Keating MJ; Valdivieso M; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1978 Apr; 62(4):493-7. PubMed ID: 350386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical trial of rubidazone in solid tumors and malignant lymphomas.
    Skovsgaard T; Hansen HH; Mouridsen HT; Nissen NI; Pedersen-Bjergaard J
    Cancer Treat Rep; 1978 Jul; 62(7):1053-8. PubMed ID: 356967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.
    Lück HJ; Thomssen C; du Bois A; Untch M; Lisboa B; Köhler G; Diergarten K
    Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-35-S17-39. PubMed ID: 9374090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
    Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cyclocytidine in children with advanced acute leukemia and solid tumors.
    Finklestein JZ; Higgins G; Krivit W; Hammond D
    Cancer Treat Rep; 1979 Aug; 63(8):1331-3. PubMed ID: 89907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I trial of rubidazone (NSC 164011) in children with cancer.
    Tan CT; Mitta SK; Steinherz L; Miller DR
    Med Pediatr Oncol; 1981; 9(4):347-53. PubMed ID: 7266427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase 1 and 2 trial of rubidazone in patients with acute leukemia.
    Benjamin RS; Keating MJ; McCredie KB; Bodey GP; Freireich EJ
    Cancer Res; 1977 Dec; 37(12):4623-8. PubMed ID: 270389
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase I-II evaluation of cyclocytidine.
    Burgess MA; Bodey GP; Minow RA; Gottlieb JA
    Cancer Treat Rep; 1977; 61(3):437-43. PubMed ID: 68828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical study of rubidazone (22 050 R.P.), a new daunorubicin-derived compound, in 170 patients with acute leukemias and other malignancies.
    Jacquillat C; Weil M; Gemon-Auclerc MF; Izrael V; Bussel A; Boiron M; Bernard J
    Cancer; 1976 Feb; 37(2):653-9. PubMed ID: 1062226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of patients over 50 years of age with acute myelogenous leukemia with a combination of rubidazone and cytosine arabinoside, vincristine, and prednisone (ROAP).
    Keating MJ; McCredie KB; Benjamin RS; Bodey GP; Zander A; Smith TL; Freireich EJ
    Blood; 1981 Sep; 58(3):584-91. PubMed ID: 6942848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of acute leukemia].
    Jacquillat C; Weil M; Auclerc MF; Schaison G; Holland JF
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):293-313. PubMed ID: 270098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II evaluation of rubidazone (NSC-164011) in advanced carcinoma of the breast. A Southwest Oncology Group study.
    Smith FE; Gad-el-Mawla N; Tranum B; Baker LH; Panettiere FJ; Athens JW; Foulkes M
    Invest New Drugs; 1983; 1(4):315-9. PubMed ID: 6678878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia.
    Kantarjian HM; Estey EH; Plunkett W; Keating MJ; Walters RS; Iacoboni S; McCredie KB; Freireich EJ
    Am J Med; 1986 Sep; 81(3):387-94. PubMed ID: 3463209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.